QNTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Quantum Biopharma Ltd.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 26, 2026
$2.41−0.06 (-2.43%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$11.75 (−82.98%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Operating income
-$12.31M
Free cash flow
–
Reported periodTrailing twelve months